Medpace Holdings, Inc. (MEDP)

USD 331.0

(-5.02%)

Market Cap (In USD)

10.28 Billion

Revenue (In USD)

1.88 Billion

Net Income (In USD)

282.81 Million

Avg. Volume

310.14 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
277.72-459.77
PE
-
EPS
-
Beta Value
1.367
ISIN
US58506Q1094
CUSIP
58506Q109
CIK
1668397
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Dr. August James Troendle M.D.
Employee Count
-
Website
https://www.medpace.com
Ipo Date
2016-08-11
Details
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.